Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Lundbeck and Vernalis disclose novel LRRK2 inhibitors

Nov. 10, 2014

New methyltransferase inhibitors designed by U.S. researchers

Nov. 10, 2014

Merck & Co. patent reports new HIV integrase inhibitors

Nov. 10, 2014

Pfizer patents novel PCSK9 inhibitors

Nov. 10, 2014

Sage Therapeutics discloses new GABA(A) receptor modulators

Nov. 10, 2014

Investigators at CSIR report new anticancer rohitukine analogues

Nov. 7, 2014

Actelion researchers present novel antibacterial compounds

Nov. 7, 2014

Astellas Pharma discloses new D1 receptor PAMs

Nov. 7, 2014

Sage Therapeutics synthesizes novel GABA(A) receptor modulators

Nov. 7, 2014

Incyte divulges novel FGFR-1, -2 and -3 inhibitors

Nov. 7, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...